New Delhi

In a move aimed at strengthening patient safety and improving oversight of medicines, the Union Health Ministry has amended drug regulations to ensure that syrups, including cough syrups, can no longer be sold without a valid prescription from a registered medical practitioner.

According to official sources, the decision seeks to bring syrup-based medicines under a more rigorous regulatory framework amid growing concerns over drug quality and public health.

The changes have been incorporated through the Drugs (Fifth Amendment) Rules, 2026, which have been published in the Official Gazette and have come into force with immediate effect.

Under the revised provisions, the government has removed the term "syrups" from Item 7 listed under the "Class of Drugs" category in Schedule K of the Drugs Rules, 1945.

Schedule K outlines categories of medicines that are exempt from certain requirements relating to their manufacture, sale and distribution under the Drugs and Cosmetics Act and its accompanying rules, subject to specified conditions.

By excluding syrups from this exempted category, authorities intend to subject these formulations to stricter controls and closer monitoring.

The amendment follows a draft notification issued by the Health Ministry in December last year inviting feedback and suggestions from stakeholders, including industry representatives and members of the public.

Officials said the responses received during the consultation process were reviewed before the final decision was taken in consultation with the Drugs Technical Advisory Board (DTAB), the country's highest statutory body dealing with technical matters related to pharmaceuticals.

The latest regulatory tightening comes against the backdrop of heightened global scrutiny of cough syrups and other liquid oral medicines.

In recent years, reports of contamination-linked fatalities involving children in multiple countries prompted Indian regulators to strengthen quality checks and manufacturing standards for such products.

According to sources, the new amendment is expected to improve accountability and traceability in the supply chain of syrup-based medicines.

By requiring prescriptions for their sale, regulators believe manufacturers, distributors and retailers will be compelled to adhere more closely to licensing norms and quality-control protocols.

Officials said the measure is intended to safeguard patients while ensuring that liquid formulations, particularly cough syrups that are often widely used and easily accessible, are dispensed more responsibly and under proper medical supervision.

READ MORE: Asra Anjum revived Dakni deserts to preserve culinary heritage

The move marks another step in the government's broader efforts to reinforce confidence in India's pharmaceutical regulatory system and prevent misuse or quality lapses involving commonly consumed medicines.